Applikationssuche / -filter
Klassifizierung | Dokumentenname | Verbindung | Produktcode | Säule | |
Pharmaceuticals, Drugs, Metabolites | 7 THC Related Compounds on Meteoric Core C18 | Cannabidiolic acid (CBDA) Cannabigerol (CBG) Cannabidiol (CBD) Cannabinol (CBN) Δ9-Tetrahydrocannabinol (Δ9-THC) Δ8-Tetrahydrocannabinol (Δ8-THC) Tetrahydrocannabinolic acid (THCA) | CAS08SQ7-1046PT | Meteoric Core C18 | |
Pharmaceuticals, Drugs, Metabolites | 7 THC Related Compounds on YMC-Triart C18 | Cannabidiolic acid (CBDA) Cannabigerol (CBG) Cannabidiol (CBD) Cannabinol (CBN) Δ9-Tetrahydrocannabinol (Δ9-THC) Δ8-Tetrahydrocannabinol (Δ8-THC) Tetrahydrocannabinolic acid (THCA) | TA12S05-2546PTH | YMC-Triart C18 | |
Pharmaceuticals, Drugs, Metabolites | Paroxetine Hydrochloride | Paroxetine related compound B Paroxetine hydrochloride | TM12S05-2546WT | YMC-Pack TMS | |
Pharmaceuticals, Drugs, Metabolites | Ibuprofen | Ibuprofen | KSB99S05-2546WT | CHIRAL ART Cellulose-SB | |
Pharmaceuticals, Drugs, Metabolites | Paroxetine Hydrochloride | Paroxetine related compound B Paroxetine hydrochloride | TM12S05-2546WT | YMC-Pack TMS | |
Pharmaceuticals, Drugs, Metabolites | Lamivudine | Lamivudine | TA12S05-2546WT | YMC-Triart C18 | |
Pharmaceuticals, Drugs, Metabolites | Fenoprofen | Fenoprofen | KSA99S05-2546WT | CHIRAL ART Amylose-SA | |
Pharmaceuticals, Drugs, Metabolites | Fexofenadine Hydrochloride Tablets | Fexofenadine hydrochloride | TA12S05-1046WT | YMC-Triart C18 | |
Pharmaceuticals, Drugs, Metabolites | Flurbiprofen | Flurbiprofen | KSA99S05-2546WT | CHIRAL ART Amylose-SA | |
Pharmaceuticals, Drugs, Metabolites | Risperidone Tablets, Fine Granules and Oral Slution (JP 16th|Assay) | Risperidone | AA30S03-1503WT | YMC-Pack ODS-A | |
Pharmaceuticals, Drugs, Metabolites | Ketoprofen | Ketoprofen | KSC99S05-2546WT | CHIRAL ART Cellulose-SC | |
Pharmaceuticals, Drugs, Metabolites | Analysis of leuprorelin acetate using YMC-Triart Bio C18 | Leuprorelin acetate (Leuprolid acetate) | TA30S03-1046PTH | YMC-Triart Bio C18 | |
Pharmaceuticals, Drugs, Metabolites | Risperidone Tablets, Fine Granules and Oral Slution (16th|Related substances) | Risperidone | AA30S03-1503WT | YMC-Pack ODS-A | |
Pharmaceuticals, Drugs, Metabolites | Risperidone Tablets and Fine Granules (JP 16th|Dissolution) | Risperidone | TA12S05-1546WT | YMC-Triart C18 | |
Pharmaceuticals, Drugs, Metabolites | Analysis of zopiclone in human hair by chiral LC/HRMS | Zopiclone | KSC99S03-1502WT | CHIRAL ART Cellulose-SC | |
Pharmaceuticals, Drugs, Metabolites | Risperidone (JP 16th|Related substances) | Risperidone | TA12S03-1046WT | YMC-Triart C18 | |
Pharmaceuticals, Drugs, Metabolites | Phenoxybenzamine | Phenoxybenzamine | KSJ99S05-2546WT | CHIRAL ART Cellulose-SJ | |
Pharmaceuticals, Drugs, Metabolites | Carvedilol tablets (JP 16th|Assay) | Carvedilol Isoamyl p-hydroxybenzoate (I.S.) | TA12S05-1546WT | YMC-Triart C18 | |
Pharmaceuticals, Drugs, Metabolites | Ketorolac | Ketorolac | KSJ99S05-2546WT | CHIRAL ART Cellulose-SJ | |
Pharmaceuticals, Drugs, Metabolites | COVID-19 agent molnupiravir | Molnupiravir β-d-N4-hydroxycytidine (NHC) | TA12SP9-05Q1PT | YMC-Triart C18 |